Bioavlee Overview

  • Founded
  • 2016
  • Status
  • Private
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $540K
Latest Deal Amount
  • Investors
  • 2

Bioavlee General Information


Operator of a biotechnology platform intended to redefine the way bacteria's are identified. The company's platform offers a patented laser diffraction-based technology that provides unprecedented accuracy, speed, versatility and value, enabling clients to identify species and strains of bacteria based on the characteristics of the figures extracted from a specific spectrum of bacterial colonies.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Primary Office
  • Ul. Krakowska 141-155
  • Wrocław, 50-428
  • Poland
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Bioavlee Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 17-Sep-2018 $540K Completed Generating Revenue
1. Early Stage VC Completed Startup
To view Bioavlee’s complete valuation and funding history, request access »

Bioavlee Executive Team (3)

Name Title Board Seat Contact Info
Michal Wronecki Chairman & Chief Executive Officer
Marek Jaroslawski Chief Technology Officer
Roman Wydra Director, Business Development
To view Bioavlee’s complete executive team members history, request access »

Bioavlee Board Members (1)

Name Representing Role Since
Michal Wronecki Bioavlee Chairman & Chief Executive Officer 000 0000
To view Bioavlee’s complete board members history, request access »

Bioavlee Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Dolnośląskie Fundusz Rozwoju Government 000 0000 000000 0
Leonarto Venture Capital Minority 000 0000 000000 0
To view Bioavlee’s complete investors history, request access »